Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 4/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NAMPT | P43490 | 2/20 | 0.38 |
| ▸ | GLS | O94925 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 2/20 | 0.37 |
| ▸ | DRD4 | P21917 | 2/20 | 0.37 |
| ▸ | DRD3 | P35462 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5246240 | 0.90 | NPC1 (0.39) | BRD4NPC1RAB9ASMN1; SMN2NAMPT | |
| SCHEMBL5248693 | 0.89 | BRD4 (0.46) | BRD4GAANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL5248477 | 0.88 | BRD4 (0.47) | BRD4NPC1RAB9ASMN1; SMN2NAMPT | |
| Trifluoroacetic Acid SCHEMBL5245621 | 0.88 | GLS (0.42) | BRD4NPC1RAB9AGLS | |
| SCHEMBL5243944 | 0.87 | SMPD1 (0.39) | BRD4 | |
| SCHEMBL5245878 | 0.87 | BRD4 (0.42) | BRD4NPC1RAB9ASMN1; SMN2NAMPT | |
| SCHEMBL5247498 | 0.86 | SMPD1 (0.39) | BRD4NPC1RAB9ADRD2DRD4 | |
| SCHEMBL5244405 | 0.86 | KMT2A (0.38) | BRD4NPC1RAB9ASMN1; SMN2NAMPT | |
| SCHEMBL5244829 | 0.86 | BRD4 (0.37) | BRD4 | |
| SCHEMBL5246566 | 0.86 | NPC1 (0.47) | BRD4GAANPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1867331-A1 | TRIAZOLE DERIVATIVE AND THE USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2007-12-19 | — | — | EP | disclosed |